On Tuesday, Basic Energy Services, Inc (NYSE:BAS)‘s shares declined -6.91% to $7.81.
Basic Energy Services, Inc (BAS) declared it will release its first quarter 2015 financial results after the market closes on Thursday, April 23, 2015. In conjunction with the release, Basic has planned a conference call that will be broadcast live over the Internet on Friday, April 24, 2015, starting at 9:00 a.m. Eastern Time (8:00 a.m. Central Time).
Basic Energy Services, Inc. provides well site services to oil and natural gas drilling and producing companies in the United States. Its Completion and Remedial Services segment offers pumping services, such as cementing, acidizing, fracturing, nitrogen, and pressure testing; rental and fishing tools; coiled tubing; snubbing services; thru-tubing; cased-hole wireline services; and underbalanced drilling in low pressure and fluid sensitive reservoirs.
Penn Virginia Corporation (NYSE:PVA)’s shares dropped -6.63% to $7.18.
Penn Virginia Corporation (PVA) declared that it will release its first quarter 2015 results after the market closes on Monday, May 11, 2015, and hold a conference call / webcast on Tuesday, May 12, 2015, at 10:00 a.m. ET.
Penn Virginia Corporation, an independent oil and gas company, explores, develops, and produces crude oil, natural gas liquids, and natural gas in various onshore regions of the United States.
At the end of Tuesday’s trade, ICON PLC (NASDAQ:ICLR)‘s shares dipped -6.50% to $6.33.
ICON PLC (ICLR) declared the release of the book “Re-Engineering Clinical Trials” (ISBN:9780124202467), edited and co-authored by Brendan Buckley, ICON’s Chief Medical Officer, and Peter Schüler, ICON’s SVP of Global Medical and Safety Services.
Joined by co-authors at AstraZeneca, Bayer, Boehringer Ingelheim, IBM, McGill University, the Tufts Center for the Study of Drug Design, and 22 other institutes and companies, Buckley and Schüler set forth a comprehensive collection of reforms for a progressive model of drug development. The editors hope to propel faster change in some businesses restrained increasingly by companies, not regulators.
ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. It develops, manages, and analyzes programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
Callon Petroleum Company (NYSE:CPE), ended its Tuesday’s trading session with -6.28% loss, and closed at $8.50.
Callon Petroleum Company (CPE) declared that the borrowing base under its senior secured revolving credit facility remained unchanged at $250 million following its lenders’ regularly planned semi-annual redetermination process. There were no other changes to the terms of the credit facility resulting from this borrowing base redetermination.
Fred Callon, Chairman and CEO, commented, “We are happy that our credit facility’s borrowing base remained unchanged following the recent redetermination cycle, despite the substantial decreases in commodity prices over the last few months.
Callon Petroleum Company engages in the exploration, development, acquisition, and production of oil and natural gas properties in the Permian Basin in West Texas. As of December 31, 2014, its estimated net proved reserves totaled 32.8 million barrel of oil equivalent, counting 25.7 million barrels of oil and 42.5 billion cubic feet of natural gas.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
